leisure time -WSS

leisure time

author：hotspot 2025-09-27 21:55:59 - browse：267

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Americans' trust in science, scientist continues decline: Report

hotspot

Wikipedia

WSS

Patients' immediate access to test results puts radiologists in a bind

Spinal cord stimulation reduces pain in amputees, study finds

Snowpack in the West is melting rapidly. Where will all that extra water go?

Chemotherapy shortages won’t get better under Biden’s latest plan

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Judge orders hearing on Trump's motion to disqualify Fulton County DA

hotspot

leisure time

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Trump team launching legal defense fund to help pay legal bills

Affirmative action in medical school literally saved lives

Radiology is caught between AI's potential and concern for patients

Dobbs anniversary: the lost opportunity of abortion as health care

Snowpack in the West is melting rapidly. Where will all that extra water go?

DIEP, the 'gold standard' of breast reconstruction, is under threat

HCA says smaller share of spending going to labor

focus

Pharma patents targeted by Biden in move to slash drug prices

American TikTok star stuck in Dubai for months following rental car altercation

American TikTok star stuck in Dubai for months following rental car altercation

Campaign finance charge dropped from case against Sam Bankman

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Poland's lawmakers approve a divisive law on Russian influence

hotspot

knowledge

Wikipedia

focus